• Protocols

• NCI10559

  OPEN TO ACCRUAL

  PII Erdafitinib for Recurrent or Progressive IDH-WT Glioma w/FGFR-TACC Gene Fusion
  
  

• UW22120

  OPEN TO ACCRUAL

  ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma